HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis
Author(s) -
Tiejun Zhao,
Zhilong Wang,
Jinyong Fang,
Wenzhao Cheng,
Yiling Zhang,
Jinhua Huang,
Lingling Xu,
Hongwei Gou,
Linghui Zeng,
Zhigang Jin,
Masao Matsuoka
Publication year - 2022
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2115316119
Subject(s) - hippo signaling pathway , effector , microbiology and biotechnology , carcinogenesis , regulator , signal transduction , biology , cell growth , suppressor , yap1 , transcription factor , cancer research , genetics , gene
Significance The Hippo pathway plays critical roles in controlling cell proliferation, and its dysregulation is widely implicated in numerous human cancers. YAP, a Hippo signaling effector, often acts as a nexus and integrator for multiple prominent signaling networks. In this study, we discover NF-κB cross talk with the Hippo pathway and identify p65 as a critical regulator for YAP nuclear retention and transcriptional activity. Furthermore, we find that p65-induced YAP activation is essential for maintaining the proliferation of ATL cells in vitro and in vivo. Our findings unravel the functional interplay between NF-κB and YAP signaling and provide mechanistic insights into the YAP-dependent growth control pathway and tumorigenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom